KONINKLIJKE PHILIPS NV
RYLPF
|
News
|
$20.515
3.85%
7K
|
Health Technology
(0.0% 1d) (0.1% 1m) (9.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (4418.83% volume)
Earnings Calendar:
Market Cap: $ 18,644,860,868
http://www.philips.com
Sec Filling | Patents | n/a employees
(NL) Royal Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
diagnostics respiratory treatment optical
add to watch list Paper trade email alert is off
Sysmex Corporation/ADR
SSMXF
|
$15.949
0.39%
1.1K
|
Health Technology
(0.0% 1d) (-71.3% 1m) (-76.6% 1y) (0.0% 2d) (-3.3% 3d) (0.0% 7d) (-95.51% volume)
Earnings Calendar:
Market Cap: $ 10,037,329,561
http://www.sysmex.co.jp
Sec Filling | Patents | n/a employees
(JP) Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
diagnostics
add to watch list Paper trade email alert is off
Sonova Holding AG / ADR
SONVF
|
$281.7
-10.2%
210
|
Health Technology
(0.0% 1d) (-7.3% 1m) (-13.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (5150.0% volume)
Earnings Calendar:
Market Cap: $ 16,796,872,095
http://www.sonova.com
Sec Filling | Patents | n/a employees
(CH) Sonova Holding AG engages in the development and production of hearing care solutions. It operates through the Hearing Instruments and Cochlear Implants business segments. The Hearing Instruments segment includes the activities related to the design, development, production, distribution, and servicing of hearing instruments and related products. The Cochlear Implants segment involves the activities relevant to the design, development, production, distribution, and servicing of hearing implants and related products. The firm offers its products under the brands Phonak, Unitron, Hansaton, Connect Hearing, Boots Hearingcare, AudioNova, Geers, and Advanced Bionics. The company was founded in 1947 and is headquartered in Staefa, Switzerland.
brands
add to watch list Paper trade email alert is off
Cochlear Ltd / ADR
CHEOF
|
$210.0
-6.47%
6
|
Health Technology
(0.0% 1d) (-6.2% 1m) (25.3% 1y) (-0.9% 2d) (-0.5% 3d) (0.0% 7d) (0.0% volume)
Earnings Calendar:
Market Cap: $ 13,753,759,740
http://www.cochlear.com
Sec Filling | Patents | n/a employees
(AU) Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.
bone
add to watch list Paper trade email alert is off
Shandong Weigao Group Medical Polymer Co Limited/ADR
SHWGF
|
$1.67
0
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-90.0% volume)
Earnings Calendar:
Market Cap: $ 7,552,294,440
http://www.weigaogroup.com
Sec Filling | Patents | n/a employees
(CN) Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical devices. It operates through the following segments: Single Use Medical Device Products, Orthopedic Products, and Others. The Single Use Medical Device Products segment involves in the production and sale of single use consumables such as infusion sets, syringes, blood transfusion sets, and blood bags. The Orthopedic Products segment includes production and sale of orthopedic products such as platelet segregator, blood plasma catheter, and blood cell segregator. The Others segment consists of finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.
t-cell ceiling
add to watch list Paper trade email alert is off
ConvaTec Group PLC/ADR
CNVVF
|
$3.685
-18.0%
6.4K
|
Health Technology
(0.0% 1d) (-3.0% 1m) (31.6% 1y) (0.0% 2d) (0.0% 3d) (-5.0% 7d) (2130.18% volume)
Earnings Calendar:
Market Cap: $ 7,553,474,525
http://www.convatec.com
Sec Filling | Patents | n/a employees
(GB) ConvaTec Group Plc operates as holding company, which engages in medical business. Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care and management, continence and critical care, and infusion devices used in the treatment of diabetes and other conditions. The company was incorporated in 1978 and is headquartered in Reading, the United Kingdom.
treatment diabetic diabetes
add to watch list Paper trade email alert is off
Elekta AB / ADR
EKTAF
|
$7.56
-34.66%
1K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-9.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-96.39% volume)
Earnings Calendar:
Market Cap: $ 2,786,522,558
http://www.elekta.com
Sec Filling | Patents | n/a employees
(SE) Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. Elekta operates through the following geographical segments: North and South America; Europe, Middle East and Africa; and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.
cancer treatment
add to watch list Paper trade email alert is off
Safilo Group SpA/ADR
SAFLF
|
$1.3
3.85%
10K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-0.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1566.67% volume)
Earnings Calendar:
Market Cap: $ 537,869,106
http://www.safilogroup.com
Sec Filling | Patents | n/a employees
(IT) Safilo Group SpA engages in the design, manufacture and distribution of prescription frames, sunglasses and sports eyewear under licensing agreements for luxury and premium brands as well as under its own brands. It operates through the Wholesale and Retail business segments. The Wholesale segment incorporates the entire business cycle of product design, research and development, production, marketing and communication, distribution, and logistics of its products. The Retail segment markets its products in specialist stores and shops worldwide. The company was founded by Guglielmo Tabacchi in 1934 and is headquartered in Padua, Italy.
brands communication
add to watch list Paper trade email alert is off
MedAvail Holdings Inc.
MDVL
4
|
$1.8
-0.56%
250K
|
Health Technology
(0.0% 1d) (0.0% 1m) (527.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (187.57% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 2,905,040
https://medavail.com
Sec Filling | Patents | 15 employees
(US) MedAvail Holdings, Inc. is a technology-enabled pharmacy company. It provides turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. The firm helps patients to optimize drug adherence, resulting in better health outcomes. The company is headquartered in Mississauga, Canada.
optical
add to watch list Paper trade email alert is off
ViewRay, Inc.
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
(0.0% 1d) (0.0% 1m) (-97.9% 1y) (0.0% 2d) (0.0% 3d) (-39.9% 7d) (32.05% volume)
Earnings Calendar: 2023-08-01
Market Cap: $ 4,585,051
http://www.viewray.com
Sec Filling | Patents | 309 employees
(US) ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. It develops MRIdian to address the limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that defines the tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova in 2004 and is headquartered in Oakwood Village, OH.
magnetic resonance radiation therapy treatment
add to watch list Paper trade email alert is off
Zosano Pharma Corporation
ZSAN
|
$0.5576
7.23%
-5.85%
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (-9.9% 3d) (0.0% 7d) (97.18% volume)
Earnings Calendar: 2022-08-10
Market Cap:
http://www.zosanopharma.com
Sec Filling | Patents | 56 employees
(US) Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. The firm focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. It offers Qtrypta, a formulation of zolmitriptan delivered utilizing the intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA.
microneedle system qtrypta
add to watch list Paper trade email alert is off
ANGLE plc
ANPCF
|
$0.148
641.22%
5K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-11.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1011.11% volume)
Earnings Calendar:
Market Cap: $ 38,565,921
https://angleplc.com
Sec Filling | Patents | n/a employees
(GB) ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D. W. Newland in April 1994 and is headquartered in Guildford, the United Kingdom.
msa ceiling diagnostics cancer t-cell
add to watch list Paper trade email alert is off
Antares Pharma, Inc.
ATRS
|
$5.59
0.0%
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (53.54% volume)
Earnings Calendar: 2022-08-04
Market Cap:
http://www.antarespharma.com
Sec Filling | Patents | 178 employees
(US) Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.
injection ycombinator
Drugs
Otrexup (methotrexate)XYOSTED (testosterone enanthate)
add to watch list Paper trade email alert is off
Apollo Endosurgery, Inc.
APEN
|
$10.0
0.75%
1.7M
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-53.84% volume)
Earnings Calendar: 2023-05-02
Market Cap: $ 579,719,190
http://apolloendo.com
Sec Filling | Patents | 217 employees
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, OverStitch Sx Endoscopic Suturing System, and Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas; inadvertent perforation of the GI tract; tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon; the treatment of swallowing disorders; esophageal stent fixation and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.
gastrointestinal endoscopy treatment
add to watch list Paper trade email alert is off
ConforMIS, Inc.
CFMS
|
$2.26
0.44%
0
|
Health Technology
(0.0% 1d) (0.4% 1m) (41.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar: 2023-11-01
Market Cap: $ 17,803,134
http://www.conformis.com
Sec Filling | Patents | 271 employees
ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. It operates through the following geographical segments: United States; Germany; and Rest of the World. The firm's products include iUni, iDuo, iTotal CR, and iTotal. The company was founded by Philipp Lang in 2004 and is headquartered in Billerica, MA.
add to watch list Paper trade email alert is off
Cyanotech Corporation
CYAN
|
$0.33
-0.03%
38K
|
Health Technology
(0.0% 1d) (-1.6% 1m) (-65.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1313.93% volume)
Earnings Calendar:
Market Cap: $ 2,292,591
http://www.cyanotech.com
Sec Filling | Patents | 95 employees
Cyanotech Corp. engages in the development and commercialization of natural products derived from microalgae. Its products include BioAstin natural astaxanthin, a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health; and Spirulina Pacifica, a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.
skin energy cardiovascular eye msa
add to watch list Paper trade email alert is off
Eargo, Inc.
EAR
|
$2.57
7.78%
200K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-52.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (2984.13% volume)
Earnings Calendar: 2023-11-02
Market Cap: $ 53,385,286
http://www.eargo.com
Sec Filling | Patents | 239 employees
Eargo, Inc. develops next generation hearing aids and headsets solutions. It offers Eargomax, a new chip for maximum audio fidelity and noise reduction and Eargoplus a superior hearing technology designed for first time hearing aid users. The company was founded by Florent Michel, Raphael Michel and Daniel Shen on November 12, 2010 and is headquartered in San Jose, CA.
audio chip
add to watch list Paper trade email alert is off
Cardiovascular Systems, Inc.
CSII
|
$20.0
-0.05%
400K
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (22.61% volume)
Earnings Calendar: 2023-05-04
Market Cap: $ 843,960,960
http://www.csi360.com
Sec Filling | Patents | 779 employees
(US) Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The firm's products are catheter-based platforms capable of treating a range of vessel sizes and plaque types. The company was founded in 1989 and is headquartered in St. Paul, MN.
cardiovascular
add to watch list Paper trade email alert is off
Heska Corporation
HSKA
|
$119.99
0.0%
390K
|
Health Technology
(0.0% 1d) (0.0% 1m) (2.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (87.26% volume)
Earnings Calendar: 2023-08-08
Market Cap: $ 1,309,541,342
http://www.heska.com
Sec Filling | Patents | 386 employees
(US) Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through two segments: Core Companion Animal Health and Other Vaccines & Pharmaceuticals. The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines. The Other Vaccines & Pharmaceuticals segment focuses on private label vaccine and pharmaceutical production, primarily for cattle, but also for equine, porcine, avian, feline, and canine. Heska was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.
vaccine animals diagnostics veterinary
add to watch list Paper trade email alert is off
Chembio Diagnostics, Inc.
CEMI
|
$0.455
-5.25%
350K
|
Health Technology
(0.0% 1d) (0.0% 1m) (1.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (62.64% volume)
Earnings Calendar: 2023-03-30
Market Cap: $ 16,710,265
http://www.chembio.com
Sec Filling | Patents | 324 employees
Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY.
infectious disease diagnostics veterinary
add to watch list Paper trade email alert is off
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
GBR | $1.33 23.15% 560K
|
Energy Minerals
Last 48 Hours Insiders Buying
CLSD | $1.42 7.58% 130K
|
Health Technology
|
14:00
CDZI P 25000 | $2.25 100K
|
Utilities
|
14:00
ETST P 39000 | $0.068 43K
|
Manufacturing
|
13:30
FNLC P 1275 | $22.62 2.08% 8K
|
Finance
|
12:30
ADMQ | $0.0532 480K
|
|
10:30
AXR P 2400 | $21.02 -5.19% 3.5K
|
Finance
|
21:00
QCRH P 118 | $56.48 1.93% 15K
|
Finance
|
18:01
VUZI P 7500 | $1.26 230K
|
Electronic Technology
|
18:00
RMCF | $3.57 0.56% 7.9K
|
Consumer Non-Durables
|
20:10